Kaposi's sarcoma

For limited cutaneous KS, regular follow-up every 3-6 months is recommended to monitor for disseminated disease. Disseminated and visceral KS requires regular follow-up with oncology and/or radiation oncology, depending on the therapeutic regimen selected. For people living with HIV, regular monitoring of CD4+ T-cell count and HIV viral load should be performed.

Less frequent oncologic monitoring (every 6-12 months) may be considered for select patients with stable disease for 2 years or longer. This may include people living with HIV if they have an undetectable HIV viral load, normal CD4+ T-cell count, and regular follow-up with an HIV specialist.[2]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Kaposi sarcoma [internet publication]. https://www.nccn.org/guidelines/category_1